GTF2A2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.729800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.303000E-01
Normal-vs-Stage2
6.354600E-01
Normal-vs-Stage3
9.236400E-01
Normal-vs-Stage4
8.139400E-01
Stage1-vs-Stage2
1.893790E-01
Stage1-vs-Stage3
3.515600E-01
Stage1-vs-Stage4
1.921400E-01
Stage2-vs-Stage3
7.144800E-01
Stage2-vs-Stage4
7.088400E-01
Stage3-vs-Stage4
9.996200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.391600E-01
Normal-vs-AfricanAmerican
5.096400E-01
Normal-vs-Asian
8.842800E-01
Caucasian-vs-AfricanAmerican
3.379400E-01
Caucasian-vs-Asian
1.661170E-01
AfricanAmerican-vs-Asian
4.271800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.490000E-01
Normal-vs-Female
4.783200E-01
Male-vs-Female
3.997800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.126000E-01
Normal-vs-Age(41-60Yrs)
3.191800E-01
Normal-vs-Age(61-80Yrs)
6.878600E-01
Normal-vs-Age(81-100Yrs)
7.480600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.967200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.988200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.909400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.116640E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.926300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.750200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.930200E-01
Normal-vs-Daily Drinker
7.458400E-01
Normal-vs-Weekly Drinker
7.862800E-01
Normal-vs-Occasional Drinker
3.226000E-01
Normal-vs-Social Drinker
7.494200E-01
Non Drinker-vs-Daily Drinker
8.123400E-01
Non Drinker-vs-Weekly Drinker
9.151400E-01
Non Drinker-vs-Occasional Drinker
4.892400E-02
Non Drinker-vs-Social Drinker
9.512600E-01
Daily Drinker-vs-Weekly Drinker
9.288000E-01
Daily Drinker-vs-Occasional Drinker
1.256430E-01
Daily Drinker-vs-Social Drinker
7.702400E-01
Weekly Drinker-vs-Occasional Drinker
1.592950E-01
Weekly Drinker-vs-Social Drinker
8.780200E-01
Occasional Drinker-vs-Social Drinker
6.650200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.048800E-01
Normal-vs-Grade 2
9.045400E-01
Normal-vs-Grade 3
9.377200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.998400E-01
Grade 1-vs-Grade 3
6.226800E-01
Grade 1-vs-Grade 4
9.048800E-01
Grade 2-vs-Grade 3
4.290200E-01
Grade 2-vs-Grade 4
9.045400E-01
Grade 3-vs-Grade 4
9.377200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.644800E-01
Normal-vs-NonDiabetic
5.242400E-01
Diabetic-vs-NonDiabetic
1.490150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.469800E-01
Normal-vs-NoPancreatitis
5.838400E-01
Pancreatitis-vs-NoPancreatitis
6.092800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.282400E-01
Normal-vs-N1
5.846200E-01
N0-vs-N1
6.784800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.848000E-01
Normal-vs-TP53-NonMutant
7.332800E-01
TP53-Mutant-vs-TP53-NonMutant
8.769600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
